Log In
BCIQ
Print this Print this
 

Intacept, biosimilar etanercept

  Manage Alerts
Collapse Summary General Information
Company Intas Pharmaceuticals Ltd.
DescriptionBiosimilar of etanercept
Molecular Target Tumor necrosis factor (TNF) alpha ; Lymphotoxin alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Biosimilar
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentMarketed
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today